These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy. De Rycke L, Kruithof E, Van Damme N, Hoffman IE, Van den Bossche N, Van den Bosch F, Veys EM, De Keyser F. Arthritis Rheum; 2003 Apr; 48(4):1015-23. PubMed ID: 12687543 [Abstract] [Full Text] [Related]
5. Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up. Kruithof E, Van den Bosch F, Baeten D, Herssens A, De Keyser F, Mielants H, Veys EM. Ann Rheum Dis; 2002 Mar; 61(3):207-12. PubMed ID: 11830424 [Abstract] [Full Text] [Related]
9. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann RK, Gamir ML, Wulffraat N, Marodi L, Petty RE, Joos R, Zulian F, McCurdy D, Myones BL, Nagy K, Reuman P, Szer I, Travers S, Beutler A, Keenan G, Clark J, Visvanathan S, Fasanmade A, Raychaudhuri A, Mendelsohn A, Martini A, Giannini EH, Paediatric Rheumatology International Trials Organisation, Pediatric Rheumatology Collaborative Study Group. Arthritis Rheum; 2007 Sep; 56(9):3096-106. PubMed ID: 17763439 [Abstract] [Full Text] [Related]
10. Predictors of infusion reactions during infliximab treatment in patients with arthritis. Kapetanovic MC, Larsson L, Truedsson L, Sturfelt G, Saxne T, Geborek P. Arthritis Res Ther; 2006 Sep; 8(4):R131. PubMed ID: 16869978 [Abstract] [Full Text] [Related]
11. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha. Eriksson C, Engstrand S, Sundqvist KG, Rantapää-Dahlqvist S. Ann Rheum Dis; 2005 Mar; 64(3):403-7. PubMed ID: 15297281 [Abstract] [Full Text] [Related]
12. Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial. Ferraccioli GF, Assaloni R, Di Poi E, Gremese E, De Marchi G, Fabris M. Rheumatology (Oxford); 2002 Oct; 41(10):1109-12. PubMed ID: 12364628 [Abstract] [Full Text] [Related]
14. Induction of autoantibodies during prolonged treatment with infliximab. Louis M, Rauch J, Armstrong M, Fitzcharles MA. J Rheumatol; 2003 Dec; 30(12):2557-62. PubMed ID: 14719194 [Abstract] [Full Text] [Related]
18. Use of infliximab in the treatment of psoriasis. Lee MR, Cooper AJ. Australas J Dermatol; 2004 Aug; 45(3):193-5. PubMed ID: 15250904 [No Abstract] [Full Text] [Related]
19. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, Smolen J, Emery P, Harriman G, Feldmann M, Lipsky P. Lancet; 1999 Dec 04; 354(9194):1932-9. PubMed ID: 10622295 [Abstract] [Full Text] [Related]
20. IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis. Visvanathan S, Wagner C, Smolen J, St Clair EW, Hegedus R, Baker D, Keenan G. Arthritis Rheum; 2006 Sep 04; 54(9):2840-4. PubMed ID: 16948115 [Abstract] [Full Text] [Related] Page: [Next] [New Search]